AT&T wins $2.4bn bid for 5G spectrum license at the FCC Auction 103
By Akshay Kedari  Date: 2020-04-01

AT&T wins $2.4bn bid for 5G spectrum license at the FCC Auction 103
  • Stakeholders and consumers may access 5G on unlimited wireless plans of AT&T.
     
  • There was a 102 percent surge in spectrum strength as they propelled 39 GHz spectrum to 786 MHz.

AT&T has won the bid for 5G spectrum licenses amounting $2.4 billion, covering over 99% of the U.S. population at the FCC Auction 103. The winning bid is poised to boost continued improvements and developments to the wireless network.

AT&T was quoted saying that the existing spectrum enabled the telecom operator to boost coverage in 2019 and outdo its competitors to serve consumers, businesses and first responders in the U.S.

Stakeholders, including business and consumers may access 5G on unlimited wireless plans of AT&T, providing extra capacity and speed over high-band spectrum to serve places such as campuses, arenas and other high traffic areas in parts of 35 cities for customers.

President at AT&T Technology & Operations Scott Mair noted that winning the contiguous block of spectrum in Auction 103 will be instrumental in maintaining the 5G hegemony across the landscape.

According to reports, there was a 102 percent surge in spectrum strength as they propelled 39 GHz spectrum to 786 MHz. It is worth noting that Auction 103 didn’t happen before AT&T had bought FiberTower in a $207 million deal in 2018 which saw the company acquire 379 MHz of 39 GHz spectrum.

It was also reported that all 39 GHz licenses with AT&T before the auction were swapped for vouchers. The company allegedly spent around $2.4 bn in the auction, translating into $1.2 bn net of the vouchers. The value of FCC issued vouchers are believed to have been determined through the auction price for the PEAs wherein the pre-auction licenses were held.

Apparently, average spectrum depth held by AT&T in mmWave surged to over 1,040 MHz, following the addition to the mmWave spectrum.

Source credit:

https://www.telecomlead.com/5g/att-bolsters-5g-spectrum-for-2-4-bn-during-fcc-auction-103-94600

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...

RADCOM introduces automated assurance solution for 5G technology
RADCOM introduces automated assurance solution for 5G technology
By Akshay Kedari

5G technology has been in the headlines for quite a while. Next-generation technology has the potential to transform almost every sector across the world. However, as 5G becomes reality, it has become imperative for service providers to prevent degra...

Sprout to expand wellness solutions lineup by acquiring Vivametrica
Sprout to expand wellness solutions lineup by acquiring Vivametrica
By Akshay Kedari

Sprout, a Canadian company that focuses on delivering innovative solutions for workplace wellbeing, has recently announced the acquisition of predictive health data analytics firm, Vivametrica. According to reliable sources, Sprout plans to enhance t...

Uber halts decision to shift APAC headquarters from Singapore
Uber halts decision to shift APAC headquarters from Singapore
By Akshay Kedari

Uber Technologies Inc., the American ride-hailing giant, has reportedly halted the company’s decision to relocate its Asia Pacific headquarters from Singapore to Hong Kong until December 2022. Sources cite that the company’s decision was...

PCI Pharma extends global clinical supply-chain services in Europe
PCI Pharma extends global clinical supply-chain services in Europe
By Akshay Kedari

U.S. based biopharmaceutical and pharma outsourcing services company, PCI Pharma services has reportedly announced that it reached a noteworthy milestone through the development of COE (Clinical Center of Excellence) in Berlin. According to credible...